Olmesartan Medoxomil/Rosuvastatin Calcium

奥美沙坦酯/瑞舒伐他汀钙

Report date: 2022/09/08 15:17:23

Base Information

Drug NameOlmesartan Medoxomil/Rosuvastatin Calcium
Drug Alias NameRosuvastatin/Olmesartan Medoxomil瑞舒伐他汀钙奥美沙坦酯奥美沙坦酯瑞舒伐他汀钙Olmesartan Medoxomil and Rosuvastatin瑞舒伐他汀钙/奥美沙坦酯 +[11] 
ClassificationSmall molecules
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsHMG-CoA reductase inhibitors
TargetsAngiotensin II Receptor Type 1HMG-CoA reductase
Therapy Area/IndicationsDyslipidemiasHypertension
Global Approved IndicationsDyslipidemiasHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritorySouth Korea
Original Approved Date2014/01/29
Country/TerritorySouth KoreaMainland China
CombinationsYes Olmesartan MedoxomilRosuvastatin Calcium
Global Highest StatusApproved
Highest Status in ChinaIND
Originator CompaniesDaewoong Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDaewoong Pharmaceutical Co LtdBeijing Daewoong Pharmaceutical R&D Center Co Ltd
Inactive CompaniesN/A
Active IndicationsDyslipidemiasHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC09D
Related LinksN/A